Furthermore, 2-aminopyridine-4-carboxamide (2-APQC), an activator of SIRT3, significantly attenuates myocardial fibrosis by inhibiting the JNK pathway and enhancing mitochondrial function [48]. The gene discussed is MAPK8; the disease is Myocardial fibrosis.